// Publications

// Select publication year: 2005
53. Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function. Transplantation 2005, 80:1204-1211. (IF 5.3)

Russ G, Segoloni G, Oberbauer R, Legendre C, Mota A, Eris J, Grinyo JM, Friend P, Lawen J, Hartmann A, Schena FP, Lelong M, Burke JT, Neylan JF; for the Rapamune Maintenance Regimen Study Group.

52. Transcriptional response in the unaffected kidney after contralateral hydronephrosis or nephrectomy. Kidney Int 2005, 68:2497-2507. (IF 14.8)

Hauser P, Kainz A, Perco P, Bergmeister H, Mitterbauer C, Schwarz C, Regele HM, Mayer B, Meyer TW, Oberbauer R.

51. Detection of coregulation in differential gene expression profiles. BioSystems 2005, 82:235-247. (IF 3.336)

Perco P, Kainz A, Mayer G, Lukas A, Oberbauer R, Mayer B.

50. Differential expression of alphaB-crystallin and Hsp27-1 in anaplastic thyroid carcinomas because of tumor-specific alphaB-crystallin gene (CRYAB) silencing. Cell Stress & Chaperones 2005, 10:171-184. (IF 3.3)

Mineva I, Gartner W, Hauser P, Kainz A, Löffler M, Wolf G, Oberbauer R, Weissel M, Wagner L.

49. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transplant Int 2005, 18:22-18. (IF 2.7)

Oberbauer R, Segoloni G, Campistol JM, Kreis H, Mota A, Lawen J, Russ G, Grinyo JM, Stallone G, Hartmann A, Pinto JR, Chapman J, Burke JT, Brault Y, Neylan JF.

SCIENTIFIC COLLABORATIONS